Zinzino AB (publ)
A listed company with a genuinely enforced customer requirement, growth it largely bought, and four regulators on its case in eighteen months.
The best customer-to-partner ratio in the category, attached to the worst advertising record.
Can you actually make money with Zinzino?
No, not as an earning proposition, and it is a shame to write that about the company with the best customer ratio on this site. There is no income disclosure anywhere, in any jurisdiction, after twenty-one years of operating as a listed issuer filing audited accounts. The only partner earnings figure in the public record belongs to the founders themselves, and it appears in the annual report rather than in a disclosure.
What this company does better than almost anything graded here is the retail gate. From month five a partner needs four Personal Customer Points, and personal purchasing cannot satisfy them - you have to have real customers who are not you. It is enforced, and the result shows up in the numbers: roughly 500,000 customers against 40,000 partners, about twelve and a half to one. Joining is free and there is no mandatory autoship.
Against that sits the worst advertising record in this file. A Swedish Consumer Ombudsman prohibition order carrying a per-violation penalty of SEK 1.5 million. Three Norwegian food-authority decisions upheld as a serious and clear breach. A municipal labeling order. Three self-regulatory cases in which the same post recurred.
And the growth is largely bought rather than grown. In Q1 2026 two acquisitions alone accounted for 46% of the revenue increment, and including the earlier cohort the organic figure looks closer to 4%. The regional table says the same thing with no estimation at all: every fast-growing region is one where a distributor base was purchased, while the home Nordic market is down 6% and Eastern Europe down 12%.
kits $60–$3,181; nothing mandatory to join
- An income disclosure. Twenty-one years, a Nasdaq First North listing and audited IFRS accounts, and there is still no published figure anywhere in the world for what a partner earns.
- A Fast Start bonus that is not weighted roughly 90/10 toward recruitment. The customer requirement points the plan at selling and this one bonus points it back the other way.
- Advertising that regulators stop having to act on. Four of them in eighteen months, with the same post recurring across three separate self-regulatory cases, is a pattern rather than an incident.
- Organic growth reported separately from acquired growth in the company's own numbers, rather than left for a reader to derive from the business-combination notes.
That call is computed, not chosen - the rule reads three of the nine published dimension scores and is printed on the methodology page. It describes this company's plan and the figures it publishes about the people already in it. It is not a prediction about you, and nothing on this site is advice.
Legal status
LEGAL - a listed Swedish issuer, currently under a Consumer Ombudsman prohibition order carrying a per-violation penalty.
Confidence: Medium-High
Primary sources fetched directly where possible. Everything we could not verify is listed at the bottom of this page by name.
Follow the money
A Swedish listed nutrition company selling omega-3 oil and a dried-blood-spot fatty-acid test through a 2:1 binary compensation plan, to roughly 500,000 customers served by roughly 40,000 partners.
Start with the thing this company does better than almost anything else we have graded. From month five, a partner must hold four Personal Customer Points, and personal purchasing cannot satisfy them - you have to have actual customers who are not you. It is enforced, and the result is visible in the numbers: about twelve and a half customers for every partner. In a category where the customer and the distributor are usually the same person, that ratio is the single strongest fact available, and it should be stated before anything else.
The concept is also coherent. You take a test, you get a number for your omega-6 to omega-3 ratio, you take the oil, you retest and the number moves. That is a real feedback loop and it is why customers reorder. Whether moving that particular ratio produces the health outcomes the field talks about is a separate and contested question, and it is precisely where the regulators have landed.
The growth story is where the report turns. Headline revenue growth looks spectacular, but the company has been buying distributor bases - a series of acquisitions of other network-marketing companies. The IFRS business-combination notes disclose per-acquisition revenue, and they let you do the arithmetic. In FY2025 acquisitions supplied about 28% of the increment, so that year was genuinely strong organically. In Q1 2026 two acquisitions alone accounted for 46% of the increment, and including the earlier cohort the organic figure looks closer to 4%. The regional table tells the same story without any estimation at all: every fast-growing region is one where a distributor base was purchased, and every pure legacy region is flat or shrinking - the home Nordic market down 6%, Eastern Europe down 12%.
Customers against partners
The ratio a genuinely enforced customer requirement produces
| Product | Price | Pays |
|---|---|---|
| Joining as a partner No mandatory purchase to hold a partner position. Genuinely zero at the door. |
Free — |
— |
| Training kit Optional. The cheapest real entry point. |
$60 one-time |
— |
| BalanceOil + test The core product and the reason customers reorder. The retest is what makes the loop work. |
~$100–150 per cycle |
plan-dependent |
| Partner Kits Optional but heavily promoted. The top kit is one of the larger optional entry purchases in the category. |
$499–$3,181 one-time |
— |
| Team commission 2:1 binary with a weekly cap per income center of roughly $1,725. |
10–15% monthly |
on the weaker binary leg |
| Fast Start bonus The part of the plan that points at recruiting rather than at selling, and the main structural criticism. |
weighted ~90/10 recruitment |
— |
Who runs it, and what they ran before
Founded the business with Hilde Sæle in 2005 and remains a controlling shareholder. No fraud finding located. The Sæles took SEK 58 million in partner compensation in 2024 - about 3.6% of group revenue and roughly 5.5% of all partner bonuses - while also controlling the company.
Co-founder and joint recipient of the compensation above. Approximately SEK 224 million across six years.
Founders who both control the company and sit at the top of its compensation plan hold two positions whose interests do not always align with the field's. That is a structural observation, not an allegation.
Registered address
Gothenburg, Sweden
A publicly listed Nordic issuer filing audited IFRS accounts. Every revenue figure in this report is auditable, which is rare in this category and is why the acquisition analysis below is possible at all.
The veteran's checklist
Eight questions that decide whether this is a business or a transfer mechanism. Same eight, every review.
| Question | Answer |
|---|---|
| Who legally owns it? |
WATCH
Zinzino AB (publ), listed on Nasdaq First North. Founders remain controlling shareholders.
|
| Where is it incorporated? |
OK
Sweden, headquartered in Gothenburg. Audited IFRS accounts, publicly filed.
|
| Regulatory action, ever? |
RED
Yes, and recently. A Swedish prohibition order (2026) with a SEK 1.5m per-violation penalty, three Norwegian decisions upheld (2026), a municipal labeling order and three self-regulatory cases.
|
| Published income disclosure? |
RED
None, in any jurisdiction, in twenty-one years.
|
| What does it take to break even? |
OK
Joining is free. Staying commission-eligible needs four real customers from month five - and personal purchases do not count.
|
| Do I own the list? |
WATCH
No. The company owns the customer relationship and the billing.
|
| Is there genuine retail demand? |
OK
Yes - roughly 500,000 customers against 40,000 partners. The best ratio in any file we have graded.
|
| Merchant play or miner play? |
WATCH
Genuinely mixed. The customer requirement pushes toward merchant; the Fast Start bonus pulls back toward miner.
|
What has to be true for you to get paid
| To cover | You need |
|---|---|
| Hold your partner position | $0 joining is genuinely free |
| Stay commission-eligible from month 5 | 4 Personal Customer Points personal purchases do not count |
| Cover a $499 Partner Kit | ~5–8 customer cycles at typical commission |
| Earn from the binary | Balanced legs under a 2:1 cap and a weekly cap per income center |
Read this twice
The month-five requirement is the most important line here and it cuts both ways. It is genuinely good consumer protection - you cannot buy your own way to qualification, which eliminates the classic failure mode of this industry. It is also a real hurdle: four actual customers, sustained, or you stop earning. Most people who join anything do not find four customers, and this plan does not let them pretend otherwise.
Run your own numbers
Drag the sliders. Nothing here is stored or sent.
Commission on a retained customer buying the oil-and-test cycle. Joining is free, so there is no monthly cost - but from month five you must hold four Personal Customer Points, and your own purchases do not count toward them. Your own subscription cost of $0/mo is included.
What it costs to replace this yourself
What the same intervention costs a customer buying it independently. This is the honest consumer test, and it is where the price-to-value dimension is decided.
| What they sell you | What you'd use instead | Your cost |
|---|---|---|
| Omega-3 oil, monthly supply | Third-party-tested high-EPA/DHA fish oil | $15–30/mo |
| Dried blood spot fatty-acid test | An independent omega-3 index test | $50–100 once |
| Retest after 120 days | The same independent test again | $50–100 |
| Fibre supplement | Psyllium husk or generic prebiotic fibre | $8–15/mo |
| Personalized report and coaching | A dietitian consultation, once | $80–150 once |
| Total as sold ~$1,200–1,800/yr |
Total, built yourself ~$400–700/yr |
Price-to-value
Roughly a 2 to 3x premium. What you are buying at the top of that range is the personalization loop and the accountability, which some people genuinely need. What you are not buying is chemistry unavailable elsewhere - the oil is oil, and independent tests measure the same ratio.
Three operators, five horizons
Probability of cumulative net profit
Hover any point for median, top decile and bottom quartile.
Part-timer
10 hrs/wk, warm market, no ads
| Horizon | P(profit) | Median |
|---|---|---|
| 3 mo | 34% | −$180 |
| 6 mo | 42% | −$60 |
| 1 yr | 44% | +$340 |
| 3 yr | 40% | +$1,400 |
| 5 yr | 36% | +$2,200 |
Full-timer
40 hrs/wk, buys traffic, builds both legs
| Horizon | P(profit) | Median |
|---|---|---|
| 3 mo | 12% | −$3,600 |
| 6 mo | 22% | −$4,800 |
| 1 yr | 32% | −$2,400 |
| 3 yr | 40% | +$18,000 |
| 5 yr | 40% | +$34,000 |
Health professional
Existing client base, sells the test honestly
| Horizon | P(profit) | Median |
|---|---|---|
| 3 mo | 56% | +$900 |
| 6 mo | 62% | +$2,800 |
| 1 yr | 62% | +$7,000 |
| 3 yr | 58% | +$22,000 |
| 5 yr | 54% | +$36,000 |
Methodology note. MODELED from the published compensation plan. No income disclosure exists in any jurisdiction, so there is nothing to calibrate against - which is itself the most important fact in this section. The health-professional row scores best because the product actually fits a practice, and because that seller can talk about the test without straying into the claims territory that has drawn four regulators in eighteen months.
Where you are actually allowed to promote this
Platform policy reads, not verifications. Check every one before you spend a dollar - enforcement changes faster than the written policy does.
Red flags and green flags
Red flags
121A Consumer Ombudsman prohibition order with a per-violation penalty
2Three food-authority decisions upheld as a serious and clear breach
3Three self-regulatory cases, with the same post recurring
4A municipal labeling order on a product
5No income disclosure exists anywhere, after twenty-one years
6The founders took roughly 5.5% of all partner bonuses
7Headline growth is largely purchased
8Every legacy region is flat or shrinking
9The Fast Start bonus is weighted about 90/10 toward recruitment
10Partner Kits run to $3,181
11A 2:1 binary with a weekly cap
12The health claim is contested where it matters most
Green flags
81Roughly twelve and a half customers for every partner
2A customer requirement that personal purchasing cannot satisfy
3Joining is genuinely free
4A listed company filing audited IFRS accounts
5A real product with a real feedback loop
6No securities exposure of any kind
7Founder compensation is disclosed rather than hidden
8Twenty-one years of continuous operation
We would like to be wrong about this
Upward
- Publication of a partner income disclosure with a median, a distribution and a percentage earning nothing - in any jurisdiction.
- A clean advertising record across a full review cycle, with the Swedish and Norwegian matters closed and no recurrence.
- Disclosure of organic versus acquired growth in the results themselves, rather than leaving it to be derived from business-combination notes.
Downward
- Enforcement of the per-violation penalty under the existing prohibition order, or a further national regulator action.
- Failure to meet the correction deadline set by the Norwegian authority.
- Evidence that organic growth has turned negative once acquisitions are stripped out.
Grade is C−. The customer requirement is the best structural feature in any plan we have graded. The advertising record is the worst.
It is worth being precise about the tension in this file, because it is unusual. Structurally, this company does the hard thing: it requires real customers, it does not let you buy your own qualification, and the result is half a million people buying product who are not in the compensation plan. That is what everybody in this industry claims and almost nobody delivers.
And then the marketing undoes it. Four regulators in eighteen months, a prohibition order with a per-violation penalty attached, a second national authority calling the breach serious and clear, and the same self-regulatory complaint recurring across two separate cases. The Swedish order matters most because of what it rejected: the company argued the marketing was its partners' doing, and the regulator said no. If you are the partner, that cuts the other way too - the person who published it is the person who owns it.
The growth picture compounds the problem. The concept works, and then a market saturates in about a decade, and the response has been to buy another distributor base. That is a legitimate corporate strategy and a poor basis for a personal one, because you would be joining a mature market rather than an expanding one. The honest version of this business is a health professional selling a measurement to clients who need it - small, compliant, durable, and nothing like the pitch.
Sell the test, not the promise
Offering a measurement is compliant. Describing what the number will do to someone's health is what has drawn two national regulators, and the liability lands personally on whoever published it.
Check which market you are actually joining
Legacy regions are flat or shrinking; growth regions are ones where a distributor base was purchased. The regional table in the annual report is public and it answers this before you commit.
Treat the top Partner Kit as marketing, not inventory
Joining is free. Nothing in the plan requires a $3,181 purchase, and no income disclosure exists to justify one.
Serve the field instead of joining it
Around 40,000 partners operating under some of the strictest health-claim law in the world, with no compliant marketing assets provided to them. Compliance-safe copy, claim libraries and practitioner-grade materials are a merchant business against a demonstrated, regulator-created need.
Nine dimensions, weighted
Dimension profile
Further from center is better. Hover any point.
Hard caps that bind here
The lowest binding cap wins, regardless of the weighted arithmetic.
What we read
Every source below links to the document itself. Tier 1 is a primary record - the company’s own plan, policy or disclosure, a court filing, a regulator’s decision or an SEC filing. Tier 2 is a self-regulatory or secondary regulator record, tier 3 reporting or academic work, tier 4 an open-market price comparison. Where a document can be moved or withdrawn, an archived copy is linked beside it. If a link is dead when you try it, that is a correction we want.
- Zinzino Compensation Plan (EU, English master version), stamped 24-04-2026 (PDF)
zinzino.com - product pages, US shop pricing, partner kit prices, compensation plan PDF stamped 24-04-2026
Not established by this document: Partner Kit (Basic/Advanced/Ultimate) prices are named in the compensation plan but Zinzino does not publish a public partner-kit price page; only the customer-facing Premier Kit prices are retrievable.
- Zinzino Compensation Plan - USA edition, stamped 10-04-2026 (PDF)
- Zinzino US shop - Premier Kits index with listed and subscription prices
- Zinzino US shop - BalanceOil+ Premium kit with Test, $226 kit plus $66/month (product page)
- Zinzino AB (publ) Annual Report 2025 - audited IFRS accounts, business combinations, regional revenue tables (PDF)
Zinzino AB annual report and interim reports - audited IFRS accounts, business-combination notes, regional revenue tables, founder compensation
- Zinzino AB (publ) Årsredovisning 2025 - Swedish statutory annual report (PDF)
- Zinzino AB (publ) Year-End Report 2025, published 25 February 2026 (PDF)
- Zinzino AB (publ) Interim Report Q1 2026 - ItWorks and Sanki acquisitions, regional revenue (PDF)
- Zinzino AB (publ) Investor Relations - report archive and Nasdaq First North Premier Growth Market disclosures
- Föreläggande mot Zinzino AB, diarienummer 2024/1136 - Konsumentombudsmannen prohibition order, SEK 1.5 million penalty per prohibition
Swedish Consumer Ombudsman prohibition order, dnr 2024/1136, March 2026 - SEK 1.5 million per-violation penalty
Not established by this document: Konsumentverket publishes only a summary page for dnr 2024/1136; the full föreläggande document must be requested from the agency and is not online.
- "Zinzino förbjuds att använda otillbörliga hälsopåståenden" - Konsumentverket press statement, 19 March 2026
- "KO stoppar Zinzinos hälsopåståenden i marknadsföringen" - Finwire market report on the prohibition order
- "Mattilsynet slår ned på Zinzinos markedsføring: – Alvorlig og klart brudd" - Dagens Næringsliv on the Norwegian Food Safety Authority inspection and three notified decisions
Norwegian Food Safety Authority - three decisions upheld 2 June 2026, correction deadline 17 August 2026
Not established by this document: Mattilsynet does not publish individual enforcement decisions; the three Zinzino vedtak were obtained by Dagens Næringsliv and Finansavisen under innsyn and are not available as public documents.
- "Mattilsynet fatter vedtak mot Sæle-bedrift: – Kan gi opphav til frykt" - Dagen, reporting the three decisions and the 17 August 2026 correction deadline
- "Sweden & Norway target Zinzino illegal medical claims" - BehindMLM summary of the 2 June 2026 Finansavisen report on the upheld citations
- Mattilsynet - Ernærings- og helsepåstander (the claims-regulation framework the three decisions apply)
- "Myndighetens larm om Zinzino: 'Otillåtna påståenden'" - EFN on the Gothenburg Miljöförvaltningen decision on ZinoBiotic+ following a RASFF notification, inspection 26 June 2025
Municipal labeling order concerning a fibre product, 2025
Not established by this document: Gothenburg Miljöförvaltningen does not publish its food-control decisions online; the 2025 ZinoBiotic+ labeling order is known only through EFN's reporting on the document.
- "Zinzino får kritik från myndigheter för sin marknadsföring" - Placera/EFN telegram noting the SEK 150,000 penalty in August 2024 and the 2025 ZinoBiotic+ decision
- ZinoBiotic+ official product sheet and EU health-claim footnotes (Sweden, sv-SE)
- DSSRC Case #38-2021: Monitoring Inquiry - Zinzino, LLC (COVID-19 and 'health and wealth' earnings claims)
BBB National Programs DSSRC files, 2021, 2023 and 2025
- DSSRC Case #129-2023: Monitoring Inquiry - Zinzino, LLC (eleven health-related product performance claims)
- DSSRC Case #196-2025: Monitoring Inquiry - Zinzino, LLC (earnings and product performance claims on YouTube, Facebook, LinkedIn and Instagram)
- DSSRC Case #225-2025: Administrative Closure - Zinzino AB (asset purchaser of Valentus Global, Inc.), acquisition completed 11 April 2025
- "Zinzino — Solid operating leverage", Carlsquare commissioned equity research update, Q1 2026 (PDF): models sub-10% organic growth for 2026 against >30% in 2025
Independent analyst coverage modeling organic growth for 2026
- "Zinzino — Healthy scalability", Carlsquare commissioned equity research update, Q4 2025 (PDF)
- "Equity research Zinzino: Preview Q2 2026 — Tepid growth with margin expansion" (17% Q2 2026 total revenue growth)
What we could not get
- Any partner income disclosure - none exists in any jurisdiction
- The FY2025 growth rate in local currency, as distinct from the reported SEK figure
- Paywalled Norwegian primary source documents behind the food-authority decisions
- An unresolved second price column on some partner kit listings
- Partner attrition and customer retention rates - not published
- Whether the Swedish per-violation penalty has been enforced in any instance
Not advice
This is independent analysis for decision-making, not legal, financial or investment advice. Allegations reported by third parties should be verified against primary court and regulatory records before any decision.
Researched by Claude. Reviewed by an editor.
Every report is researched and written by Claude, Anthropic’s AI assistant, from the company’s own plan documents, policies, terms and regulatory file - then reviewed before publication by Rob Fore, who checks the sources and the stage-label on every allegation.
- Nine weighted dimensions, published with their weights
- The editor checks the evidence and cannot change the number - the build rejects any page whose grade does not reconcile to its own arithmetic
- Every affiliate position we hold is disclosed on the report it touches
- No company has paid for a grade, and no report carries an affiliate link
Looking at something else?
Enter any company name or website. If a report exists it opens instantly; if not, we start one.
Zinzino - frequently asked
QIs Zinzino a pyramid scheme?
QHow much does it cost to join Zinzino?
QDoes Zinzino publish an income disclosure?
QHas Zinzino been fined or sanctioned by regulators?
QIs Zinzino actually growing?
Author, editor and publisher
This report was researched and written by Claude, Anthropic’s AI assistant, working from primary documents - Zinzino’s own compensation plan, its policies and procedures, its terms of service, its income disclosure statement where one exists, and its regulatory and self-regulatory file. It was scored against nine weighted dimensions that are published in full, with their weights, on the methodology page.
Before publication it was reviewed by Rob Fore, who checks every source link, every figure against the document it came from, and every allegation against its stage-label - an investigation is not a finding, a warning letter is not an enforcement action, and a filed claim is not a verdict.
The editor does not set the grade. The published score is the weighted composite of the nine dimension scores, and the build refuses to emit a page where the two disagree by more than 0.06. A grade moves when the evidence moves it and not otherwise.
Rob Fore has marketed online since 1996, wrote Online MLM Marketing (2014), and is CEO of Listech Inc, the Nevada corporation that publishes this site. He holds affiliate positions in companies graded here - including LiveGood, which this site grades D, SendOutCards, which it grades C−, and the Home Business Academy, which it grades B−. Those positions are disclosed on the reports they touch, and changed nothing on this page.
About the author and our conflicts · Contact the editor · Corrections: corrections@opportunitygrade.com
Tell me if this grade changes
Zinzino is graded C- as of July 27, 2026. Grades move when the evidence moves - a new income disclosure, a regulatory action, a rewritten compensation plan. Leave your address and you will get one email if this one does.
One email when the grade moves, and nothing else. We will never use your address to promote an income opportunity of any kind, we do not sell, rent or share the list, and it is stored on our own infrastructure rather than with any company graded here. Unsubscribe removes everything.
Corrections
Every factual claim on this page is sourced, and the ones we could not stand up are named in the unable to verify list above. If something here is wrong, we want to know, and we would rather hear it from Zinzino than from a reader.
Write to corrections@opportunitygrade.com. Point at the specific sentence and send the document that contradicts it - a plan document, a filing, an income disclosure, a policy page. We will check it against the primary source, correct the page if it is wrong, and say in the report that it was corrected and when. A grade moves if the evidence moves it.
This address reaches a person, not a form. We do not require a takedown demand, an NDA or a lawyer to accept a correction, and we do not remove a report because a company disputes its conclusion - only because the underlying facts turn out to be wrong.